Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data

K Cleland, N Smith - Contraception, 2015 - contraceptionjournal.org
Mifepristone was approved for sale in the United States 15 years ago this month. Use of
mifepristone has steadily increased since its introduction; medical abortions now account for …

Safety of mifepristone abortions in clinical use

JT Henderson, AC Hwang, CC Harper, FH Stewart - Contraception, 2005 - Elsevier
OBJECTIVES: Extensive data from clinical trials document mifepristone's safety and efficacy
for induced abortion, but less information is available about its safety in routine clinical use …

[引用][C] Happy anniversary mifepristone: a decade of promise and challenges

B Jordan, WC Shields - Contraception, 2010 - contraceptionjournal.org
September 29, 2010, marks the 10th anniversary of Food and Drug Administration's
approval of Mifeprex (mifepristone) in the United States. That moment 10 years ago brought …

Updates to the US food and drug administration regulations for mifepristone: implications for clinical practice and access to abortion

KE Simmonds, MW Beal… - Journal of Midwifery & …, 2017 - Wiley Online Library
This article provides information on recent changes in the US Food and Drug Administration
(FDA) labeling and safety regulations for mifepristone (Mifeprex). The revised label now …

Off-label indications for mifepristone in gynecology and obstetrics

IG Dzuba, D Grossman, CA Schreiber - Contraception, 2015 - contraceptionjournal.org
The 15th anniversary of the registration of mifepristone in the United States (US) provides an
opportunity to reflect on its history, its contribution to women's reproductive health and to …

From qualified physician to licensed health care professional: the time has come to change mifepristone's label

AM Foster, CB Jackson, KJ LaRoche… - …, 2015 - contraceptionjournal.org
In the wake of the 1973 Roe v Wade decision legalizing abortion in the United States, states
across the country enacted laws to protect women from unsafe, unlicensed abortion …

The mifepristone REMS: A needless and unlawful barrier to care✰

J Kaye, R Reeves, L Chaiten - Contraception, 2021 - Elsevier
Mifepristone (brand name Mifeprex) is a prescription drug that has been safely used in the
United States for twenty years to end early pregnancies and, more recently, to treat early …

[PDF][PDF] Mifepristone label laws and trends in use: recent experiences in four US states

WR Sheldon, B Winikoff - Contraception, 2015 - gynuity.org
In the 15 years since approval of mifepristone in the United States, there have been
numerous changes in the political, legal and medical contexts surrounding abortion …

[HTML][HTML] Abortion safety and use with normally prescribed mifepristone in Canada

L Schummers, EK Darling, S Dunn… - … England Journal of …, 2022 - Mass Medical Soc
Abstract Background In the United States, mifepristone is available for medical abortion (for
use with misoprostol) only with Risk Evaluation and Mitigation Strategy (REMS) restrictions …

Can mifepristone medical abortion be simplified?: A review of the evidence and questions for future research

WH Clark, M Gold, D Grossman, B Winikoff - Contraception, 2007 - Elsevier
Mifepristone medical abortion has been a valuable addition to the reproductive health
options of women. Aspects of its provision have however sometimes limited its accessibility …